![ecancer](http://media.vumedi.com/thumbs/channel_logo/2020/8/0bffd421-174a-4418-b45d-1b6192c3c1d9.png.200x0_q85.png)
ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2024
ecancer
Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT
FEATURING
Monzr Al Malki,
Steven Devine
- 23 views
- July 24, 2024
ecancer
ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple Myeloma"
FEATURING
Xavier Leleu
- 54 views
- July 18, 2024
- 1
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 81 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"
FEATURING
Puneeth Iyengar
- 26 views
- July 2, 2024
ecancer
ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials
FEATURING
Luis Raez
- 49 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"
FEATURING
Li Zhang
- 15 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"
FEATURING
Matteo Lambertini
- 72 views
- July 2, 2024
- 1
ecancer
ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of Tec-DR in NDMM"
FEATURING
Salomon Manier
- 59 views
- June 26, 2024
ecancer
ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"
FEATURING
Natalia Neparidze
- 62 views
- June 25, 2024
ecancer
ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"
FEATURING
Elizabeth Loggers
- 22 views
- June 24, 2024
ecancer
ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VRd in Transplant-Eligible NDMM"
FEATURING
Paula Rodríguez-Otero
- 55 views
- June 24, 2024
- 1
ecancer
ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"
FEATURING
Xavier Leleu
- 158 views
- June 24, 2024
- 1
ecancer
ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"
FEATURING
Thierry Facon
- 87 views
- June 24, 2024
ecancer
ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer"
FEATURING
Jean-Marc Classe
- 110 views
- June 21, 2024
ecancer
ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuvant CRT in Patients With Esophageal Adenocarcinoma"
FEATURING
Jens Hoeppner
- 50 views
- June 21, 2024
ecancer
ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"
FEATURING
Joseph Greer
- 14 views
- June 20, 2024
- 1
ecancer
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"
FEATURING
Jane Meisel
- 218 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adjuvant Nivo in Stage III Melanoma"
FEATURING
Christian Blank
- 32 views
- June 20, 2024
- 1
ecancer
ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"
FEATURING
Antonio Cigliola
- 37 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immediate Surgery in Fully Resectable Melanoma"
FEATURING
Axel Hauschild
- 29 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 69 views
- June 20, 2024
ecancer
ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial - Teclistamab in R/R MM"
FEATURING
Alfred Garfall
- 13 views
- June 20, 2024